Skip to main content
. 2024 Feb 9;130(8):1249–1260. doi: 10.1038/s41416-023-02550-1

Fig. 1. Biomarker selection procedure.

Fig. 1

a Scheme of study design. Created with BioRender.com, b Volcano plot of differential gene expression analysis according to primary and recurrent disease. For each gene, the log fold-change (log2FC) and the –log10 p-value are plotted. The dotted lines indicate the set cutoff values for further analysis (p < 0.05, |log2FC | > 0.8). Red dots mark the seven makers chosen for IHC.